Exagen Inc. XGN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 58.3%0.0pp | 58.3%-1.6pp | 59.9%+0.4pp | 59.4%+0.1pp | 59.3%-0.2pp | |
| Operating margin | -20.6%+0.5pp | -21.1%-1.5pp | -19.6%+4.2pp | -23.9%+0.8pp | -24.7%-0.2pp | |
| Net margin | -29.5%+0.5pp | -30%0.0pp | -29.9%-1.1pp | -28.8%-1.5pp | -27.3%-0.2pp | |
| Returns | ||||||
| Return on equity | -193.6%-45.7pp | -147.8%-25.0pp | -122.8%-34.9pp | -87.9%+29.6pp | -117.5%-23.7pp | |
| Return on invested capital | -73.7%+46.7pp | -120.5%-17.6pp | -102.9%-17.2pp | -85.6%-4.4pp | -81.3%+50.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×+0.2× | 1.3×+0.1× | 1.2×+0.1× | 1.1×-0.2× | 1.2×+0.2× | |
| Liquidity | ||||||
| Current ratio | 3.5×0.0× | 3.5×-0.6× | 4.1×-0.9× | 5×+2.6× | 2.3×-0.4× | |
| Leverage | ||||||
| Debt-to-equity | 1.9×+0.3× | 1.6×+0.1× | 1.5×+0.3× | 1.2×-2.5× | 3.7×+1.2× | |
| Per Share | ||||||
| Book value per share | $0.61-25.3% | $0.81+2.4% | $0.79-20.7% | $1.00+189% | $0.35-34.2% | |
| Valuation | ||||||
| Market capitalization | $112.34M-26.5% | $137.79M-43.0% | $241.82M+56.7% | $154.34M+140% | $64.25M-11.1% | |
| Price / sales | 1.6×-1.0× | 2.1×-1.7× | 3.8×+1.2× | 2.6×+1.5× | 1.1×-0.2× | |
| Price / book | 7.8×+0.5× | 7.9×-5.4× | 13.3×+6.0× | 7.3×-2.7× | 10×+2.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Exagen Inc.'s profit margins?
- Exagen Inc. (XGN) runs a 58.3% gross margin and a -20.6% operating margin, with a -29.5% net margin.
- Where do Exagen Inc.'s ratios come from?
- Every ratio is computed from Exagen Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
